Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Krish S. Krishnan, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | the Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
|
|
|
|
|
|
|
Date: May 7, 2018 |
|
|
| By: |
| /s/ Krish S. Krishnan |
|
|
|
|
|
| Krish S. Krishnan |
|
|
|
|
|
| President and Chief Executive Officer |
|
|
|
|
|
| (Principal Executive Officer) |
I, Antony A. Riley, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | the Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
|
|
|
|
|
|
|
Date: May 7, 2018 |
|
|
| By: |
| /s/ Antony A. Riley |
|
|
|
|
|
| Antony A. Riley |
|
|
|
|
|
| Chief Financial Officer |
|
|
|
|
|
| (Principal Accounting and Financial Officer) |
